Share Email Print
cover

Proceedings Paper

PDT opportunities in oncology practice
Author(s): M. L. Gelfond
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

The results of novel photosensitizer Photoditazine clinical trials have demonstrated high clinical potential of the drug in the PDT of 53 patients with malignant tumors. The drug has advantageous spectral, physico-chemical and energetic characteristics in comparison to currently used Russian and foreign photosensitizers.

Paper Details

Date Published: 7 December 2006
PDF: 6 pages
Proc. SPIE 5973, Current Research on Laser Use in Oncology: 2000-2004, 597309 (7 December 2006); doi: 10.1117/12.640040
Show Author Affiliations
M. L. Gelfond, N.N. Petrov Research Institute of Oncology (Russia)


Published in SPIE Proceedings Vol. 5973:
Current Research on Laser Use in Oncology: 2000-2004
Andrei V. Ivanov; Mishik A. Kazaryan, Editor(s)

© SPIE. Terms of Use
Back to Top